Congress Trades
Latest disclosures
| Chamber | Transaction Date | Member | Owner ▼ | Asset | Action | Amount | Ticker | Δ Since Trade |
|---|---|---|---|---|---|---|---|---|
| House | Apr. 10, 2024 | Dan Newhouse | Spouse | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +13.24% |
| Senate | Jan. 22, 2025 | Ron Wyden | Spouse | Eli Lilly and Company Common Stock | PURCHASE | $50,001 - $100,000 | LLY | ▲ +14.44% |
| Senate | Feb. 10, 2025 | Ron Wyden | Spouse | Eli Lilly and Company Common Stock | SALE (FULL) | $50,001 - $100,000 | LLY | ▼ -0.69% |
| Senate | Mar. 6, 2025 | Ashley Moody | Self | Eli Lilly and Co | PURCHASE | $100,001 - $250,000 | LLY | ▼ -5.47% |
| Senate | Oct. 30, 2024 | Sheldon Whitehouse | Self | Eli Lilly and Company | PURCHASE | $15,001 - $50,000 | LLY | ▲ +1.89% |
| Senate | Apr. 3, 2024 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (FULL) | $15,001 - $50,000 | LLY | ▲ +11.19% |
| Senate | Aug. 22, 2025 | John Boozman | Joint | Eli Lilly and Company | PURCHASE | $1,001 - $15,000 | LLY | ▲ +21.24% |
| Senate | Aug. 11, 2025 | John Boozman | Joint | Eli Lilly and Company | PURCHASE | $1,001 - $15,000 | LLY | ▲ +35.84% |
| Senate | Dec. 11, 2024 | Markwayne Mullin | Joint | Eli Lilly and Company Common Stock | PURCHASE | $50,001 - $100,000 | LLY | ▲ +8.40% |
| Senate | Apr. 15, 2025 | Tommy Tuberville | Joint | Eli Lilly and Co | SALE | $15,001 - $50,000 | LLY | ▲ +13.96% |
| Senate | Apr. 15, 2025 | Tommy Tuberville | Joint | Eli Lilly and Company | SALE (FULL) | $15,001 - $50,000 | LLY | ▲ +13.96% |
| Senate | Aug. 22, 2025 | John Boozman | Joint | Eli Lilly and Co | PURCHASE | $1,001 - $15,000 | LLY | ▲ +21.24% |
| Senate | Jan. 3, 2024 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $15,001 - $50,000 | LLY | ▲ +39.69% |
| Senate | Sep. 8, 2023 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▲ +47.13% |
| Senate | Sep. 13, 2023 | Markwayne Mullin | Joint | Eli Lilly and Company | PURCHASE | $15,001 - $50,000 | LLY | ▲ +44.08% |
| Senate | Jan. 14, 2022 | Tommy Tuberville | Joint | Eli Lilly and Company Common Stock | SALE (FULL) | $15,001 - $50,000 | LLY | ▲ +253.46% |
| Senate | Apr. 16, 2020 | David Perdue | Joint | Eli Lilly and Company | SALE (FULL) | $1,001 - $15,000 | LLY | ▲ +457.66% |
| House | May. 13, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +15.66% |
| House | May. 1, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | PURCHASE | $1,001 - $15,000 | LLY | ▲ +8.66% |
| House | Jul. 1, 2024 | Josh Gottheimer | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▼ -5.63% |
| House | Apr. 9, 2025 | Josh Gottheimer | Joint | Eli Lilly and Company Common Stock | SALE (PARTIAL) | $1,001 - $15,000 | LLY | ▲ +14.48% |
| House | Apr. 21, 2025 | Jonathan Jackson | Joint | Eli Lilly and Co | PURCHASE | $15,001 - $50,000 | LLY | ▲ +5.48% |
| House | Mar. 10, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +3.99% |
| House | Feb. 19, 2025 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▼ -0.48% |
| House | Dec. 13, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +9.34% |
| House | Dec. 11, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +8.40% |
| House | Dec. 10, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +7.91% |
| House | Dec. 9, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +7.38% |
| House | Dec. 18, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +12.83% |
| House | Dec. 12, 2024 | Josh Gottheimer | Joint | Eli Lilly and Co | SALE | $1,001 - $15,000 | LLY | ▲ +10.29% |
Last updated: Nov 3, 05:58